Transcriptomics

Dataset Information

3

Efficacy and molecular mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells


ABSTRACT: This report describes our study of the efficacy and the potential mechanism underlying the anti-prion action of a new anti-prion compound having a glycoside structure in prion-infected cells. The study revealed involvements of two factors in the mechanism of the compound action: interferon and a microtubule nucleation activator, phosphodiesterase 4D interacting protein. In particular, phosphodiesterase 4D interacting protein was suggested to be important in regulating the trafficking or fusion of prion protein-containing vesicles or structures in cells. The findings of the study are expected to be useful not only for the elucidation of cellular regulatory mechanisms of prion protein, but also for the implication of new targets for therapeutic development. Prion-infected N167 cells were treated with either anti-prion glycoside compound (Gly-9) or control glycoside compound (Gly-14) at a dose of 5 μg/mL for three days. Then, gene expression profiles were analyzed by DNA microarray analysis. Experiments were performed in quadruplicate.

ORGANISM(S): Mus musculus  

SUBMITTER: Katsumi Doh-ura   Keiko Nishizawa 

PROVIDER: E-GEOD-55241 | ArrayExpress | 2014-02-22

SECONDARY ACCESSION(S): GSE55241PRJNA238984

REPOSITORIES: GEO, ArrayExpress

Dataset's files

Source:
Action DRS
E-GEOD-55241.idf.txt Idf
E-GEOD-55241.processed.1.zip Processed
E-GEOD-55241.raw.1.zip Raw
E-GEOD-55241.sdrf.txt Txt
Items per page:
1 - 4 of 4

Similar Datasets

2014-01-01 | S-EPMC3993762 | BioStudies
2020-04-22 | PXD017655 | Pride
2020-04-22 | PXD017656 | Pride
2009-03-25 | E-MTAB-76 | ArrayExpress
2015-10-30 | E-MTAB-76 | ExpressionAtlas
2010-05-26 | E-GEOD-7119 | ArrayExpress
2013-01-01 | S-EPMC3679450 | BioStudies
1000-01-01 | S-EPMC5427932 | BioStudies
2018-01-01 | S-EPMC6277182 | BioStudies
2020-01-01 | S-EPMC7075655 | BioStudies